| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-07 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0002 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0003 |
| mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0004 |